New agents and strategies for the hormonal treatment of castration-resistant prostate cancer

By Sharifi Nima  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 837-846

Informa Healthcare

Access to resources Recommend Favorite

High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy

By Eastham James A  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 291-295

Informa Healthcare

Access to resources Recommend Favorite

Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment

By Resnick Matthew J.   Barocas Daniel A.   Morgans Alicia K.   Phillips Sharon E.   Chen Vivien W.   Cooperberg Matthew R.   Goodman Michael   Greenfield Sheldon   Hamilton Ann S.   Hoffman Karen E.   Kaplan Sherri H.   Paddock Lisa E.   Stroup Antoinette M.   Wu Xiao-Cheng   Koyama Tatsuki   Penson David F.  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1263-1271

Blackwell Publishing

Access to resources Recommend Favorite

Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer

By Eastham James A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite

Hormonal therapy in advanced prostate cancer examined

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite